| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5502951 | Journal of the Neurological Sciences | 2017 | 9 Pages |
Abstract
In this retrospective assessment of treatment-recalcitrant fulminant inflammatory CNS syndromes, HDMTX-LR was observed to be a safe and highly effective treatment, producing the rapid and near complete cessation of disease activity, in conjunction with an important corresponding and 'durable remission' in the majority of our small treatment cohort.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Shin C. MD, Eric MD, PhD, Ram MD, Allen MD, Doug RN, Elizabeth S. PhD, MBA, Vernon MD, Dennis MD, Louis MD, Teresa C. PA-C, Benjamin MD, MHS, Elliot M. MD, PhD,